Peer Review History
| Original SubmissionJuly 21, 2024 |
|---|
|
Dear Dr. Ghimire, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Therefore, we invite you to submit a revised version of the manuscript before it can be sent to external reviewers. Discuss the study limitations on the effects of the study outcomes to fully satsfy PLOS ONE's publication criteria number 7. ============================== Please submit your revised manuscript by Oct 21 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Adaoha Pearl Agu, MBBS, MSc, FMCPH Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. 4. Please ensure that you refer to Figure 2 and 3 in your text as, if accepted, production will need this reference to link the reader to the figure. 5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 6. We are unable to open your Supporting Information file [FInal data 101.sav]. Please kindly revise as necessary and re-upload. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Ghimire, Title :The aspect of associations and predictors being explored in this study, is not reflected in the title. Abstract : State the justification for this study in the background section. State the figure for the overall proportion of women who.... in the Conclusion section. Introduction : Last sentence- "Assess" not "Access" .Grammar editing needed in this and other sections. Study Design : Restructure the first sentence to read "A community based cross-sectional study was conducted using.....from 25th September to 29th December 2022. State which stages of the immunisation schedule, the babies had to be in for their mothers to be eligible for this study.Explain why women seeking vaccination for MR 2nd dose and Typhoid were excluded. Sample Size and Sampling Methods : This phrase is not clear "hypothesis of 95% confidence interval". State the reason behind the purposive selection of the 3 wards selected. (Convenience was stated as the reason for the choice of the 3 health institutions). Explain how you selected subjects from the 3 sites and how you intended to distribute the sample size across the 3 sites. Measurement :State the outcome variables clearly. Data Analysis :State the number of components BCPR has and provide information on the scoring criteria for the knowledge variables. State the p-value <0.05 you used to set statistically significant variables in the multivariable analysis as mentioned in the abstract. Why was this value chosen? Results-->?>DiscussionReferencing : should be uniform. Please submit your revised manuscript by Sep 17 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Adaoha Pearl Agu, MBBS, MSc, FMCPH Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments (if provided): Please address the following concerns in addition to those raised by the reviewer.The entire manuscript will benefit from serious grammar and spelling editing. Title:The aspect of associations and predictors being explored in this study, is not reflected in the title. Abstract: State the justification for this study in the background section. State the figure for the overall proportion of women who.... in the Conclusion section. Introduction: Last sentence- "Assess" not "Access" .Grammar editing needed. Study Design: Restructure the first sentence to read "A community based cross-sectional study was conducted using.....from 25th September to 29th December 2022. State which stages of the immunisation schedule, the babies had to be in for their mothers to be eligible for this study.Explain why women seeking vaccination for MR 2nd dose and Typhoid were excluded. Sample Size and Sampling Methods: This phrase is not clear "hypothesis of 95% confidence interval". State the reason behind the purposive selection of the 3 wards selected. (Convenience was stated as the reason for the choice of the 3 health institutions). Explain how you selected subjects from the 3 sites and how you intended to distribute the sample size across the 3 sites. Measurement:State the outcome variables clearly. Data Analysis:State the number of components BCPR has and provide information on the scoring criteria for the knowledge variables. Results: State whether the adequate knowledge in 59.1% of the respondents, refers to a composite knowledge score (composite score is not seen on the Table with Knowledge variables- Table 2). Table 1 should be left as it is (do not split). The narrative below Table 3 begins with "Table 8"...., refers to the information contained in Table 4, and is a repetition of the narrative below Table 4. Table 3 should appear before Table 2. Table 4 subheading should read"Assistance" not "Assistant".,Merge Tables 5 and 6.Remove "other" from Table 7 title. The information in Table 8 can be presented as a narrative only, not as a table. Was a composite knowledge score used in Table 9?. Do not repeat the information presented in the figures, in the tables. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No ********** Reviewer #1: The manuscript addresses an interesting and important topic in maternal and child health and findings will support informed decisions. I, however, have few comments for the authors to consider Abstract The abstract's background only defines Birth preparedness. Kindly shed more light on it. Let us know what necessitated this study/purpose. Methods You probably want to say structured interview “tool/questionnaire” instead of schedule In the methods session, line 4 has a typographical error. Please check and correct it. Results The first sentence needs structuring Conclusion For the conclusion of the abstract, there should be an “and” between “antenatal care” and interventions, and all the commas should be removed as shown below. It will be good to give the magnitude/ proportion of women who prepared for birth and its complications Main Work Introduction 1. You need to check typos and grammatical errors. Have tried to input in the document Methods Justification for the study area is not available. Sample size calculation 1. Any justification for considering 7% as margin of error instead of 5%? In the calculation, however, 6% is used. With an expected prevalence of 29% one will have expected a smaller margin of error, at least the default 5% Besides, the paper you referenced stated that 29% lacked information on BPP and I am wondering if this is the same as prevalence of poor BPCR practice 2. How was the sample size distributed among the wards and health institutions? Measurements 3. Any reference to the previously validated questionnaire? 4. Were the regular reviews of the questionnaire done during data collection? 5. Study design needs to be written well and concisely 6. The sampling of participants for the study should be clearly written 7. Examples of obstetric and institutional factors investigated Data collection process 8. Data collection procedure needs to be written well/clearly 9. There was no mention of who did the data collection and whether training was done before the data collection Data Analysis 10. It would have been good to describe a bit more about scoring Results 11. IQR is between 25th and 75th percentiles not min and max 12. Table 1 could have been divided into three (1. Socio-demographic 2. Obstetric 3. Complication experience) instead of one table running through several pages 13. The tables need to be constructed well and referenced 14. Section on support received by women is repeated 15. Chose Fig 2 or Table 5, Fig 3 or Table 6. You should not present same data on both tables and figures Discussion 16. The discussion seemed to have repeated the results and compared with other studies but failed to discuss any implication of the findings Generally, the document needs a lot of work grammatically References Bibliography should be done well. They are not uniform. A common reference style should be used. Figures The title of all the figures should be placed below the figures, not above them. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Dear Dr. Ghimire, Please submit your revised manuscript by Dec 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Adaoha Pearl Agu, MBBS, MSc, FMCPH Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: You are yet to address point by point, the issues raised by the second reviewer. [Note: HTML markup is below. Please do not edit.] [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Birth Preparedness And Complication Readiness Knowledge, Practices and Its Associated Factors Among Recently Delivered Women: A Cross-Sectional Study In Bharatpur, Chitwan, Nepal PONE-D-24-29050R3 Dear Dr. Ghimire, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Adaoha Pearl Agu, MBBS, MSc, FMCPH Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-29050R3 PLOS One Dear Dr. Ghimire, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Adaoha Pearl Agu Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .